Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,500
Closed -$177K 2317
2022
Q1
$177K Hold
20,500
﹤0.01% 1729
2021
Q4
$228K Hold
20,500
﹤0.01% 1701
2021
Q3
$265K Buy
20,500
+3,100
+18% +$49.4K ﹤0.01% 1697
2021
Q2
$288K Sell
17,400
-2,700
-13% -$45.8K ﹤0.01% 1728
2021
Q1
$345K Hold
20,100
﹤0.01% 1679
2020
Q4
$314K Hold
20,100
﹤0.01% 1645
2020
Q3
$383K Sell
20,100
-14,400
-42% -$249K ﹤0.01% 1470
2020
Q2
$472K Buy
34,500
+13,007
+61% +$183K ﹤0.01% 1346
2020
Q1
$228K Sell
21,493
-10,707
-33% -$174K ﹤0.01% 1512
2019
Q4
$601K Sell
32,200
-15,000
-32% -$193K ﹤0.01% 1341
2019
Q3
$493K Hold
47,200
﹤0.01% 1292
2019
Q2
$357K Buy
+47,200
New +$411K ﹤0.01% 1485
2017
Q2
Sell
-4,000
Closed -$65K 2024
2017
Q1
$65K Sell
4,000
-20,500
-84% -$268K ﹤0.01% 1738
2016
Q4
$247K Hold
24,500
﹤0.01% 1517
2016
Q3
$329K Buy
24,500
+6,500
+36% +$95.4K ﹤0.01% 1445
2016
Q2
$376K Buy
18,000
+16,700
+1,285% +$241K ﹤0.01% 1404
2016
Q1
$12K Hold
1,300
﹤0.01% 1847
2015
Q4
$14K Hold
1,300
﹤0.01% 1869
2015
Q3
$19K Hold
1,300
﹤0.01% 1827
2015
Q2
$23K Buy
+1,300
New +$27K ﹤0.01% 1812

Other funds holding XBIT

STRS Ohio's XBIT Position: Q2 2022 in Review

STRS Ohio sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 20,500 shares — an estimated $177K sold.

STRS Ohio first reported a position in XBIT in Q2 2015 and held it in 20 quarters. The position peaked at $601K in Q4 2019. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

  • STRS Ohio reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 20,500 XBiotech shares in Q2 2022, an estimated $177K.
  • STRS Ohio first reported a position in XBiotech in Q2 2015 and held it in 20 quarters.
  • STRS Ohio's XBiotech position peaked at $601K in Q4 2019.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.